U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies is disrupting the work of drug, medical ...

A FDA generic drug office was eliminated — and the implications will be felt not only by drugmakers, but consumers ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

Vinay Prasad, a hematologist-oncologist known for his vocal opposition to elements of the Covid response, also jumped on Cavazzoni’s move back to Pfizer in a same-day blog post titled “FDA approves ...

The firings this week also include all staff responsible for managing records – such as new product applications – at FDA ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

The Trump administration is kicking off investigations into imports of pharmaceuticals and semiconductors as part of a bid to impose tariffs on both sectors on national security grounds, notices ...

A group of biotech CEOs, investors, and patient advocates have urged Senate HELP Committee Chairman Bill Cassidy (R-LA) to intervene amid an ongoing restructuring program at the FDA which they ...

Senior FDA leaders are anticipating that the agency’s already lagging rate of routine food and drug inspections will ...

But alongside this work, Ironwood has now engaged ... that Zealand Pharma’s bid for approval of its own GLP-2 analog SBS treatment was also batted away in December by the FDA, who demanded ...